EMD-37651

Single-particle
2.51 Å
EMD-37651 Deposition: 03/10/2023
Map released: 24/04/2024
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-37651

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-8wmf summary report (pdf.gz) Map-8wmf FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

SARS-CoV-2 EG.5.1 spike glycoprotein (closed-1 state)

EMD-37651

Single-particle
2.51 Å
EMD-37651 Deposition: 03/10/2023
Map released: 24/04/2024
Last modified: 16/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: SARS-COV-2 EG.5.1 spike glycoprotein
Fitted models: 8wmf

Deposition Authors: Nomai T , Anraku Y , Kita S , Hashiguchi T, Maenaka K
Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant.
PUBMED: 38961765
DOI: doi:10.1111/1348-0421.13165
ISSN: 1348-0421